Enhanced Angiogenic and Cardiomyocyte Differentiation Capacity of Epigenetically Reprogrammed Mouse and Human Endothelial Progenitor Cells Augments their Efficacy for Ischemic Myocardial Repair

RATIONALE: While Bone-marrow endothelial progenitor cell based therapies (BM-EPC) improve the symptoms in patients with ischemic heart disease their limited plasticity and decreased function in patients with existing heart disease limits the full benefit of EPC therapy for cardiac regenerative medic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Thal, Melissa A., Krishnamurthy, Prasanna, Mackie, Alexander R., Hoxha, Eneda, Lambers, Erin, Verma, Suresh, Ramirez, Veronica, Qin, Gangjian, Losordo, Douglas W., Kishore, Raj
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406600/
https://ncbi.nlm.nih.gov/pubmed/22589372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.112.270462
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars